β-blockers in Heart Failure - Pharmacy benefit management

Recommendation 2: There is evidence to suggest that plasma BNP or NT-proBNP testing can be helpful to identify selected patients with left ventricular systolic dysfunction in the post-MI setting or in patients at high risk of developing heart failure (e.g. history of myocardial infarction, diabetes mellitus). ................
................